Volunteer Form
Investigational Respiratory Syncytial Virus Vaccine Study
AMR Lexington is now enrolling healthy adults 60 to 85 in an investigational Respiratory Syncytial Virus (RSV) vaccine study.
Qualified participants must:
- have received an AREXVY vaccine at least 18 months before study enrollment
- meet other study criteria
Qualified participants will receive all study-related care and the investigational vaccine or placebo at no cost. Reimbursement is available up to $730.00 for study-related time and travel.
If you’re interested in learning more about this trial, you can reach out to AMR today by calling 888-259-1231 or fill out the form below and a member of our recruitment team will contact you to get started.

Refer-A-Friend
Earn extra cash* by recommending a friend to us and receive up to $100 for each referral!
Important Instructions
* Some restrictions apply. Not all studies are eligible for the Refer-A-Friend program. Ask an AMR representative for details.